Adverse effects of chronic endogenous sympathetic drive induced by cardiac Gsα overexpression

Circulation Research

Volumn 78, Issue 4, 1996, Pages 517-524

  Iwase, Mitsunori ^b   Bishop, Sanford P ^b   Uechi, Masami ^b   Vatner, Dorothy E ^b   Shannon, Richard P ^b   Kudej, Raymond K ^b   Wight, David C ^b   Wagner, Thomas E ^b   Ishikawa, Yoshihiro ^b   Homcy, Charles J ^b   Vatner, Stephen F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Echocardiography; GTP stimulatory protein; Heart failure; Sympathetic drive; Transgenic mice

Indexed keywords

ADENYLATE CYCLASE; AMINE; BETA ADRENERGIC RECEPTOR; COLLAGEN; ISOPRENALINE; NORADRENALIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART RATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; FEMALE; FIBROSIS; GTP-BINDING PROTEINS; HEART; HEMODYNAMIC PROCESSES; ISOPROTERENOL; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; NOREPINEPHRINE; REFERENCE VALUES; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 0029912925     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.4.517     Document Type: Article

References (26)

1. sα protein in the hearts of transgenic mice. J Clin Invest. 1995;95:1676-1683.
2. Alousi AA, Jasper JR, Insel PA, Motulsky HJ. Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J. 1991;5: 2300-2303.
3. Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res. 1995;77:632-637.
4. Sahn DJ, Demaria A, Kisslo J, Weyman A, for the committee on M-mode standardization of the American Society of Echocardiography. Recommendation regarding quantitation in M-mode echocardioaraphy: results of a survey of echocardiographic methods. Circulation. 1978;58:1072-1083.
5. sα. Circulation. 1995;92(suppl I):I-432. Abstract.
6. Kume H, Graziano MP, Kotlikoff MI. Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding proteins. Proc Natl Acad Sci U S A. 1992;89: 11051-11055.
7. Wang HY, Watkins DC, Malbon CC. Antisense oligodeoxynucleotidcs to Gs protein α-subunit sequence accelerate differentiation of fibroblasts to adipocytes. Nature. 1992;358:334-337.
8. Bomsel M, Mostov KE. Possible role of both the α and βγ subunits of the heterotrimeric G protein Gs, in transcytosis of the polymeric immunoglobulin receptor. J Biol Chem. 1993;268:25824-25835.
9. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657-670.
10. Robbins RJ, Swain JL. C-myc protooncogene modulates cardiac hypertrophic growth in transgenic mice. Am J Physiol. 1992;262: H590-H597.
11. Hittinger L, Mirsky I, Shen Y-T, Patrick TA, Bishop SP, Vatner SF. Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with left ventricular hypertrophy. Circulation. 1995;92:978-986.
12. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Eillingham ME, Harrison DC. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
13. Koch WJ, Milano CA, Lefkowitz RJ. Transgenic manipulation of myocardial G protein-coupled receptors and receptor kinases. Circ Res. 1996;78:511-516.
14. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ. Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science. 1994;264:582-586.
15. Koch WJ, Rockman HA, Samama P, Hamilton R, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 1995;268:1350-1353.
16. 1 adrenoceptors in transgenic mice. Cardiovasc Res. 1993;27:1606-1612.
17. Dies F, Krell MJ, Whitlow P, Liang C-S, Goldenberg I, Applefeld MM, Gilbert EM. Intermittent dobutamine in ambulatory out-patients with chronic cardiac failure. Circulation. 1986;74(suppl II):II-38. Abstract.
18. Krell MJ, Kline EM, Bates ER, Hodgson JM, Dilworth LR, Laufer N, Vogel RA, Pitt B. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J. 1986;112:787-791.
19. Lambertz H, Meyer J, Erbel R. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation. 1984;69:298-305.
20. Xamoterol in severe heart failure study group. Xamoterol in severe heart failure. Lancet. 1990;336:1-6.
21. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeildis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano RN, Shannon J, Tandon PK, DeMets DL, for the PROMISE Study research group. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325: 1468-1475.
22. Heilbrunn SN, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 1989;79:483-490.
23. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Hjalmarson A. Long-term β-blockade in dilated cardiomyopathy. Circulation. 1989;80:551-563.
24. Metra M, Nardi M, Giubbini R, Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994;24: 1678-1687.
25. Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitx FD, Bristow MR. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol. 1995;25:1225-1231.
26. Cooper DMF, Mons N, Karpen JW. Adenylyl cyclases and the interaction between calcium and cAMP signaling. Nature. 1995;374: 421-424.